Download PDF
Pharmacopsychiatry 2010; 43: S9-S20
DOI: 10.1055/s-0030-1253365
Review

© Georg Thieme Verlag KG Stuttgart · New York

Mental Illness, Synapses and the Brain – Behavioral Disorders by a System of Molecules within a System of Neurons?

F. Tretter1
  • 1Department of Addiction, Isar-Amper-Clinics, Haar/Munich, Germany
Further Information

Publication History

Publication Date:
18 May 2010 (online)

Also available at
    Permissions and Reprints

Abstract

The multi-level systems view conceiving the brain as a “network of networks of neurons” rises the question how it could be possible to understand this complex system with respect to mental functions and dysfunctions. One crucial issue is related to the analysis of the connectivity of these networks by the study of synapses. Also synapses are complex dynamical molecular systems that can only be understood by computer-based methodologies in order to analyze complex data sets and for modeling complex molecular networks. Many data are available but there is a lack models that capture the dynamic features of synapses that are involved in psychiatric disorders and psychopharmaceutical treatment. One strategy of research could be offered by Systems Biology. Here some challenges for modeling synapses in mental disorders are discussed.

References

  • 1 Abbot LF. Balancing homeostasis and learning in neural circuits.  Zoology. 2003;  106 (4) 365-371
    CrossrefPubMedGoogle Scholar
  • 2 Abbott LF, Regehr WG. Synaptic computation.  Nature. 2004;  431 (7010) 796
    CrossrefPubMedGoogle Scholar
  • 3 Abbott LF, Varela J, Sen K. et al . Synaptic depression and cortical gain control.  Science. 1997;  275 220-224
    PubMedGoogle Scholar
  • 4 Aghajanian GK, Marek GJ. Serotonin model of schizophrenia: emerging role of glutamate mechanisms.  Brain Res Rev. 2000;  31 (2–3) 302-312
    CrossrefPubMedGoogle Scholar
  • 5 Alon U. Systems Biology – Design principles of biological circuits.. New York: Chapman & Hall; 2007
    Google Scholar
  • 6 Bender W, Albus M, Möller HJ. et al . Towards systemic theories in biological psychiatry.  Pharmacopsychiatry. 2006;  39 (S 01) S4-S9
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Benes FM. Neural circuitry models of schizophrenia: is it dopamine, GABA, glutamate or something else?.  Biol Psychiatry. 2009;  65 1003-1005
    CrossrefPubMedGoogle Scholar
  • 8 Benoit-Marand M, Borrelli E, Gonomn F. Inhibition of dopamine release via presynaptic D2 receptors: time course asnd functional characteristics in vivo.  J Neurosci. 2001;  21 9134-9141
    PubMedGoogle Scholar
  • 9 Bertram R, Sherman A, Stanley EF. Single-domain/bound calcium hypothesis of transmitter release and facilitation.  J Neurophysiol. 1996;  75 1919-1931
    PubMedGoogle Scholar
  • 10 Best JA, Nijhout HF, Reed MC. Homeostatic mechanisms in dopamine synthesis and release: a mathematical model.  Theoretical Biology and Medical Modelling. 2009;  6 21 DOI: doi:10.1186/1742-4682-6-21
    CrossrefPubMedGoogle Scholar
  • 11 Brunel N, Wang X-J. Effects of neuromodulation in a cortical network model of object working memory dominated by recurrent inhibition.  J Comput Neurosci. 2001;  11 63-85
    CrossrefPubMedGoogle Scholar
  • 12 Carlsson A. The current status of the dopamine hypothesis of schizophrenia.  Neuropsychopharmacology. 1988;  1 179-186
    CrossrefPubMedGoogle Scholar
  • 13 Carlsson A. The neurochemical circuitry of schizophrenia.  Pharamcopsychiatry. 2006;  39 (Suppl. 1) S10-S14
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Carlsson M, Carlsson A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia – implications for schizophrenia and Parkinson's disease.  Trends Neurosci. 1990;  13 272-276
    CrossrefPubMedGoogle Scholar
  • 15 Carlsson A, Waters N, Carlsson ML. Neurotransmitter interactions in schizophrenia- therapeutic implications.  Eur Arch Psychiat Clin Neurosci. 1999;  249 (S 04) 37-43
    PubMedGoogle Scholar
  • 16 Carlsson A, Waters N, Holm-Waters S. et al . Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence.  Annu Rev Pharmacol Toxicol. 2001;  41 237-260
    CrossrefPubMedGoogle Scholar
  • 17 Chavas J, Marty A. Coexistence of Excitatory and Inhibitory GABA Synapses in the Cerebellar Interneuron Network.  J Neurosci. 2003;  23 (6) 2019-2031
    PubMedGoogle Scholar
  • 18 Clements JD. Transmitter timecourse in the synaptic cleft: its role in central synaptic function, Trends.  Neurosci. 1996;  19 (5) 163-171
    PubMedGoogle Scholar
  • 19 Cohen JD, Servan-Schreiber D. A theory of dopamine function and its role in cognitive deficits in schizophrenia.  Schizophr Bull. 1993;  19 85-104
    PubMedGoogle Scholar
  • 20 Cooper JR, Bloom FE, Roth RH. The Biochemical Basis of Neuropharmacology.. 8th ed., New York: Oxford University Press; 2004
    Google Scholar
  • 21 Cragg SJ, Rice ME. Dancing past the DAT at a DA synapse.  Trends Neurosci. 2004;  27 (5) 270-277
    CrossrefPubMedGoogle Scholar
  • 22 Dayan P, Abbott LF. Theoretical Neuroscience Computational and mathematical modeling of neural systems.. Cambridge, MA: MIT Press; 2005
    Google Scholar
  • 23 Durstewitz D. A few important points about dopamine's role in neural network dynamics.  Pharmacopsychiatry. 2006;  39 (S 01) S72-S75
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Durstewitz D, Seamans JK. The computational role of dopamine D1 receptors in working memory.  Neural Netw. 2002;  15 (4–6) 561-572 Review
    CrossrefPubMedGoogle Scholar
  • 25 Durstewitz D, Seamans JK, Sejnowski TJ. Dopamine-mediated stabilization of delay-period activity in a network model of prefrontal cortex.  J Neurophysiol. 2000;  83 1733-1750
    PubMedGoogle Scholar
  • 26 Fernandez E, Schiappa R, Giraul JA. et al . DARPP-32 is a robust integrator of dopamine and glutamate signals.  PLoS Comput Biol. 2006;  2 (12) e176
    CrossrefPubMedGoogle Scholar
  • 27 Fishwick PE. ed Handbook of dynamic system modeling.. New York: Chapman & Hall; 2007
    CrossrefGoogle Scholar
  • 28 von Foerster H. Understanding Understanding: Essays on Cybernetics and Cognition.. Berlin: Springer; 2002
    Google Scholar
  • 29 Freeman WJ. Neurodynamics: An exploration in mesoscopic brain dynamics.. Berlin: Springer; 2000
    Google Scholar
  • 30 Gallinat J, Obermayer K, Heinz A. Systems Neurobiology of the dysfunctional brain.  Pharmacopsychiatry. 2007;  40 (S 01) S40-S44
    Article in Thieme ConnectPubMedGoogle Scholar
  • 31 Gao W-J, Goldman-Rakic PS. Selective modulation of excitatory and inhibitory microcircuits by dopamine.  PNAS. 2003;  100 (5) 2836-2841
    CrossrefPubMedGoogle Scholar
  • 32 Gebicke-Haerter P. Systems Biology in Molecular Psychiatry.  Pharmacopsychiatry. 2008;  41 (S 01) S19-S27
    Article in Thieme ConnectPubMedGoogle Scholar
  • 33 Giuditta A, Chun JT, Eyman M. et al . Local gene expression in axons and nerve endings:the glia-neuronunit.  Physiol Rev. 2008;  89 515-555
    PubMedGoogle Scholar
  • 34 Goldman-Rakic PS. Cellular basis of working memory.  Neuron. 1995;  14 477-485
    CrossrefPubMedGoogle Scholar
  • 35 Goldman-Rakic PS. The physiological approach: functional architecture of working memory and disordered cognition in schizophrenia.  Biol Psychiatry. 1999;  456 650-661
    PubMedGoogle Scholar
  • 36 Goldman-Rakic SP, Muly III EC, Williams GV. D1 receptors in prefrontal cells and circuits.  Brain Research Rev. 2000;  31 295-301
    CrossrefPubMedGoogle Scholar
  • 37 Grace AA. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia.  Neurosci. 1991;  41 1-24
    CrossrefPubMedGoogle Scholar
  • 38 Grace AA, Bunney BS. Electrophysiological Properties of Midbrain Dopamine Neurons: Psychopharmacology – 4th Generation of Progress.  2000; 
    CrossrefPubMedGoogle Scholar
  • 39 Grant SGN. Systems biology in neuroscience: bridging genes to cognition.  Curr Opin Neurobiol. 2003;  13 (5) 577-582
    CrossrefPubMedGoogle Scholar
  • 40 Haken H. Brain dynamics.. Berlin: Springer; 2002
    Google Scholar
  • 41 Hermandez-Lopez S, Bargas J, Surmeier DJ. et al . D1 recpetor activation enhances evoked discharges in neotriatal medium spiny neurons by modulating an L-type Ca2+ conductace.  J Neurosci. 1997;  17 3334-3342
    PubMedGoogle Scholar
  • 42 Hoffman RE, Dobscha SK. Cortical pruning and the development of schizophrenia: a computer model.  Schizophr Bull. 1989;  15 (3) 477-490
    PubMedGoogle Scholar
  • 43 Kauer JA, Malenka RC. Synaptic plasticity and addiction.  Nat Rev Neurosci. 2007;  8 844-858
    CrossrefPubMedGoogle Scholar
  • 44 Kitano H. Computational Systems Biology.  Nature. 2002;  420 (6912) 206-210
    CrossrefPubMedGoogle Scholar
  • 45 Kitano H. Systems Biology: a brief overview.  Science. 2002;  295 (5560) 1662-1664
    CrossrefPubMedGoogle Scholar
  • 46 Klingauf J, Neher E. Modeling buffered Ca2+ diffusion near the membrane: Implications for secretion in neuroendocrine celly.  Biophys J. 1997;  72 674-690
    CrossrefPubMedGoogle Scholar
  • 47 Klipp E, Herwig R, Kowald A. et al .Systems Biology in Practice.. Weinheim: Wiley-VCH; 2005
    CrossrefGoogle Scholar
  • 48 Klipp E, Liebermeister W, Wierling Ch. et al .Systems Biology.. A Textbook. Weinheim: Wiley-VCH; 2009
    Google Scholar
  • 49 Koshkina E. Extracellular dopamine concentration control: computational model of feedback control.  2006;  URL: http://hdl.handle.net/1860/1160
    PubMedGoogle Scholar
  • 50 LeNovere N. The long journey to a Systems Biology of neuronal function.  BMC Syst Biol. 2007;  1 28
    CrossrefPubMedGoogle Scholar
  • 51 LeNovere N. Neurological disease: are systems approaches teh way forward?.  Pharmacopsychiatry. 2008;  41 (S 01) S28-S31
    Article in Thieme ConnectPubMedGoogle Scholar
  • 52 Lewis DA, Pierri JN, Volk DW. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia.  Biol Psychiatry. 1999;  46 616-626
    CrossrefPubMedGoogle Scholar
  • 53 Lewis DL, Hashimoto T, Volk DW. Cortical inhibitory neurons and schizophrenia.  Nat Rev Neurosci. 2005;  6 312-324
    CrossrefPubMedGoogle Scholar
  • 54 Lindskog M. Modelling of DARPP32 regulation to understand intracellular signaling in pschiatric disorder.  Pharmacopsychiatry. 2008;  41 (S 01) S99-S104
    Article in Thieme ConnectPubMedGoogle Scholar
  • 55 Lindskog M, Kim MS, Wikstrom MA. et al . Transient Calcium and Dopamine Increase PKA Activity and DARPP-32 Phosphorylation.  PLoS Comput Biol. 2006;  2 (9) e119
    CrossrefPubMedGoogle Scholar
  • 56 Lisman JE, Coyle JT, Green RW. et al . Circuit-based framework fro understanding neurotransmitter and rsik gene interactions in schizophrenia.  Trends Neurosci. 2008;  31 (5) 234-242
    CrossrefPubMedGoogle Scholar
  • 57 Markram H. Blue Brain Project.  2010;  http://http:&bluebrain.epfl.ch/page18900.html
    PubMedGoogle Scholar
  • 58 Markram H, Gupta A, Uziel A. et al . Information processing with frequency-dependent synptic connections.  Neurobiol Learn Mem. 1998;  70 101-112
    CrossrefPubMedGoogle Scholar
  • 59 Marty A, Llano I. Excitatory effects of GABA in established brain networks.  Trends Neurosci. 2005;  28 (6) 284-289
    CrossrefPubMedGoogle Scholar
  • 60 Meisenzahl EM, Scheuerecker J, Schmitt GJS. et al . Dopamine, prefrontal cortex and working memory functioning in schizophrenia.  Pharmacopsychiatry. 2007;  40 (S 01) S62-S72
    Article in Thieme ConnectPubMedGoogle Scholar
  • 61 Meyer-Lindenberg A, Weinberger DR. Intermediate phenotypes and genetic mechanisms of psychiatric disorders.  Nat Rev Neurosci. 2006;  10 818-827
    PubMedGoogle Scholar
  • 62 Moghaddam B. Bringing order to the glutamate chaos in schizophrenia.  Neuron. 2003;  40 881-884
    CrossrefPubMedGoogle Scholar
  • 63 Moore H, West AR, Grace AA. The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology.  Biol Psychiatry. 1999;  46 40-55
    CrossrefPubMedGoogle Scholar
  • 64 Nakano T, Doi T, Yoshimoto J. et al . A kinetic model of dopamine- and calcium-dependent striatal synaptic plasticity.  PLoS Comput Biol. 2010;  6 (2) e1000670
    CrossrefPubMedGoogle Scholar
  • 65 Neve KA, Seamans JK, Trantham-Davidson H. Dopamine Receptor.  J Recept Signal Transduct Res. 2004;  24 (3) 165-205
    CrossrefPubMedGoogle Scholar
  • 66 Nicola SM, Surmeier J, Malenka RC. Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens.  Annu Rev Neurosci. 2000;  23 185-215
    CrossrefPubMedGoogle Scholar
  • 67 NIH . Systems Biology.  http://www.nigms.nih.gov/Initiatives/SysBio/ 2007; 
    PubMedGoogle Scholar
  • 68 NISB. . Netherlands Institute for Systems Biology.  2009;  http://www.neurosciencecampus-amsterdam.nl/en/index.asp
    PubMedGoogle Scholar
  • 69 Noble D. Multilevel modelling in Systems Biology: From Cells to Whole Organs.. In: Szallasi Z, Periwal V, Stelling J, (Ed) System, modelling in Cellular Biology. Cambridge, MA: MIT Press; 2006: 297-312
    Google Scholar
  • 70 Noble D. The Music of Life: Biology Beyond the Genome.. New York: Oxford University Press; 2006
    Google Scholar
  • 71 Palsson BO. Systems Biology.. Cambridge: Cambridge University Press; 2006
    CrossrefGoogle Scholar
  • 72 Pocklington AJ, Armstrong JD, Grant SGN. Organization of brain complexity – synapse proteome form and function.  Brief Funct Genomic Proteomic. 2009;  5 (I) 66-73
    CrossrefPubMedGoogle Scholar
  • 73 Pocklington AJ, Cumiskey M, Armstrong JD. et al . The proteomes of neurotransmitter receptor complexes form modular networks with distributed functionality underlying plasticity and behaviour.  Mol Syst Biol. 2006;  2 2006.0023
    PubMedGoogle Scholar
  • 74 Qi Z, Miller G, Voit E. A mathematical model of presynaptic dopamine homeostasis: implications for schizophrenia.  Pharmacopsychiatry. 2008;  41 (S 01) S89-S98
    Article in Thieme ConnectPubMedGoogle Scholar
  • 75 Reckow S, Gormanns P, Holsboer F. et al . Psychiatric disorders biomarker identification From proteins to systems biology.  Pharmacopsychiatry. 2008;  41 (S 01) S70-S77
    Article in Thieme ConnectPubMedGoogle Scholar
  • 76 Scherer J, Eberle E, Tretter F. A basic mathematical model of the dopamine synapse.. In: Trappl R Hrsg. Cybernetics and Systems. Vol I. Vienna: Austrian Society for Cybernetic Studies; 2002: 335-328
    Google Scholar
  • 77 Schmitz Y, Schmauss C, Sulzer D. Altered dopamine release and uptake kinetics in mice lacking D2 receptors.  J Neurosci. 2002;  22 (18) 8002-8009
    PubMedGoogle Scholar
  • 78 Seamans JK, Yang CR. The principal features and mechanisms of dopamine modulation in the prefrontal cortex.  Progr Neurobiol. 2004;  74 1-58
    CrossrefPubMedGoogle Scholar
  • 79 Seamans JK, Durstewitz D, Christie B. et al . Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons.  Proc Natl Acad Sci USA. 2001;  98 301-306
    CrossrefPubMedGoogle Scholar
  • 80 Shepherd G. Neurobiology.. New York: Oxford University Press; 1994
    Google Scholar
  • 81 Shepherd G. The synaptic organization of the brain.. New York: Oxford University Press; 2004
    CrossrefGoogle Scholar
  • 82 Shiflet AB, Shiflet GW. Introduction to computational science.. Modeling and simulation for the sciences. Princeton, NJ: Princeton University Press; 2006
    Google Scholar
  • 83 Sjöstrom PJ, Rancz EA, Roth A. et al . Dendritic excitability and synaptic plasticity.  Physiol Rev. 2008;  88 769-840
    CrossrefPubMedGoogle Scholar
  • 84 Szallasi Z, Stelling J, Periwal V. (Ed) System modeling in cellular biology.. Cambridge, MA, MIT Press; 2006
    Google Scholar
  • 85 Tarazi FI, Baldessarini RJ. Dopamine D4 receptors: significance for molecular psychiatry at the millennium.  Mol Psychiatry. 1999;  4 529-538
    CrossrefPubMedGoogle Scholar
  • 86 Trantham-Davidson H, Neely LC, Seamans JK. Mechanisms underlying differential D1 versus D2 dopamine receptor regulation of inhibition in prefrontal cortex.  J Neurosci. 2004;  24 (47) 10652-10659
    CrossrefPubMedGoogle Scholar
  • 87 Tretter F. Systemtheorie im klinischen Kontext.. Lengerich: Pabst Science Publisher; 2005
    Google Scholar
  • 88 Tretter F, Albus M. Systems biology and psychiatry – modeling molecular and cellular networks of mental disorders.  Pharmacopsychiatry. 2008;  41 (Suppl) S2-S18
    Article in Thieme ConnectPubMedGoogle Scholar
  • 89 Tretter F, Gebicke-Haerter P. Neuropsychaitry – subject, concepts, methods and computational models.. In: Tretter F, Gebicke-Haerter P, Mendoza E, Winterer G. Sysetms Biology in Psychiatric Research. Weinheim: Wiley-VCH; (in press)
    Google Scholar
  • 90 Tretter F, Gebicke-Haerter PJ. Philosophy of neuroscience and options of systems science.  Pharmacopsychiatry. 2009;  42 (S 01) S2-S10
    Article in Thieme ConnectPubMedGoogle Scholar
  • 91 Tretter F, Müller W, Carlsson A. (Eds) Systems Science, Computational Science and Neurobiology of Schizophrenia.  Pharmacopsychiatry. 2006;  39 (S 01) S1-S88
    PubMedGoogle Scholar
  • 92 Tretter F, Müller W. (Eds) Computational Neuropsychiatry: The Functional Architecture of Working Memory Networks in Schizophrenia – Data and Models.  Pharmacopsychiatry. 2007;  40 (S 01) S1-S94
    Article in Thieme ConnectPubMedGoogle Scholar
  • 93 Tretter F, Gallinat J, Müller WE. (Eds) Systems Biology and Psychiatry: The functional architecture of molecular networks in mental disorerders – data and models.  Pharmacopsychiatry. 2008;  41 (Suppl1) S1-S106
    Article in Thieme ConnectPubMedGoogle Scholar
  • 94 Tretter F, Gebicke-Haerter P, Heinz A. (Eds) Systems Biology of Addiction.  Pharmacopsychiatry. 2009;  42 (S 01) S1-S152
    Article in Thieme ConnectPubMedGoogle Scholar
  • 95 Valor LM, Grant SGN. Integrating synapse proteomics with transcritpional regulation.  Behav Gent. 2007;  37 18-30
    PubMedGoogle Scholar
  • 96 Vernalaken I, Gründer G, Cumming P. Progress in psychopharmacotherapy through molecular imaging.. In: Tretter F, Gebicke-härter P, Mendoza E, Winterer G, (ed) Systems Biollogy in Psychiatric Research. Weinheim: Wiley-VCH; (in press)
    Google Scholar
  • 97 Vogels TP, Abbott LF. Gating deficits in model networks: a path to schizophrenia?.  Pharmacopsychiatry. 2007;  40 (S 01) S73-S77
    Article in Thieme ConnectPubMedGoogle Scholar
  • 98 Wang M, Vijayraghavan S, Goldman-Rakic PS. Selective D2 Receptor Actions on the Functional Circuitry of Working Memory.  Science. 2004;  303 853-856
    CrossrefPubMedGoogle Scholar
  • 99 Wang XJ, Tegnér J, Constandinidis C. et al . Division of labor among distinct subtypes of inhibitory neurons in a cortical microcircuit of working memory.  PNAS. 2004;  101 (5) 1368-1373
    CrossrefPubMedGoogle Scholar
  • 100 Wang XJ. Toward a prefrontal microcircuit model for cognitive deficits in schizophrenia.  Pharmacopsychiatry. 2006;  39 (S 01) S80-S87
    PubMedGoogle Scholar
  • 101 Wassef A, Baker J, Kochan LD. GABA and schizophrenia: a review of basic science and clinical studies.  J Clin Psychopharmacol. 2003;  23 (6) 601-640
    CrossrefPubMedGoogle Scholar
  • 102 Wegener N, Koch M. Neurobiology and systems physiology of the endocannabinoid system.  Pharmacopsychiatry. 2009;  42 (S 01) S79-S86
    Article in Thieme ConnectPubMedGoogle Scholar
  • 103 Wightman RM, Heien ML, Wassum KM. et al . Dopamine release is heterogeneous within microenvironments of the rat nucleus accumbens.  Eur J Neurosci. 2007;  26 2046-2054
    CrossrefPubMedGoogle Scholar
  • 104 Winterer G. Cortical microcircuits in schizophrenia – the dopamine hypothesis revisited.  Pharmacopsychiatry. 2006;  39 (S 01) S68-S71
    Article in Thieme ConnectPubMedGoogle Scholar
  • 105 Winterer G. Prefrontal dopamine signaling in schizophrenia – the corticocentric model.  Pharmacopsychiatry. 2007;  40 (S 01) S45-S53
    Article in Thieme ConnectPubMedGoogle Scholar
  • 106 Winterer G, Weinberger DR. Genes, dopamine and cortical signal-to-noise ratio in schizophrenia.  Trends Neurosci. 2004;  27 (11) 683-690
    CrossrefPubMedGoogle Scholar
  • 107 Yang ChR. Chen Targeting Prefrontal Cortical Dopamine D1 and N-methyl-D-aspartate receptor interactions in schizophrenia treatment.  Neuroscientist. 2005;  11 452-470
    CrossrefPubMedGoogle Scholar
  • 108 Zeigler BP, Praehofer H, Kim TG. Theory of modelling and simulation.. London: Elsevier Academic Press; 2000
    Google Scholar

Correspondence

Prof. Dr. Dr. Dr. F. Tretter

Department of Addiction

Isar-Amper-Clinics

85540 Haar

Germany

Phone: 089/4562-3708

Fax: 089/4562-3754

Email: felix.tretter@iak-kmo.de

      >